Peter Milligan, Ph.D.

Chief Executive Officer


  • Joined Pharmetheus in 2019, serving as Chief Executive Officer
  • Expertise includes pre-clinical and clinical pharmacology and pharmacometrics in therapeutic areas such as oncology, neuroscience, and infectious, gastrointestinal, and cardiovascular diseases
  • Previously worked as Head of Global Pharmacokinetics at Pfizer UK, where he led model informed drug development implementation across Pfizer to develop integrated analyses of relevant data informing strategy, design, and decision making in drug discovery and development, and as Staff Researcher at Syntex, UK
  • M.Sc. in Clinical Pharmacy (1987) from Strathclyde University, UK, and Ph.D. in Medicine and Therapeutics (1991) from Glasgow University, UK
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Open Systems Pharmacology Community-An Open Access, Open Source, Open Science Approach to Modeling and Simulation in Pharmaceutical SciencesModel Informed Drug Development: Collaboration Through A Common FrameworkTowards Industrialisation of Probability of Pharmacological Success (PoPS)Model-informed drug development of autologous CAR-T cell therapy: Strategies to optimize CAR-T cell exposure leveraging cell kinetic/dynamic modeling